Hunter Capital today announces that it has entered into a transaction agreement with the Danish biotechnology company ResoTher Pharma regarding a reverse acquisition. Read more here: https://www.spotlightstockmarket.com/sv/market-overview/nyheter/nyhets-artikel/?id=115861&publisher=370&_ga=2.141052470.58088122.1793196825-140098659.1767689816